ImmuniT Research
ImmuniT Research provides a platform that quantifies and monitors immunity to help predict therapeutic and diagnostic outcomes. The company combines immune analysis technologies with machine learning and AI to generate blood-based biomarkers that forecast response to immune checkpoint inhibitors such as PD-1 antibodies. Its stack includes flow cytometry and mass cytometry assays integrated into an Immunity Data Platform used for drug discovery support, biomarker development, and licensing or research collaborations. Customers are primarily pharmaceutical companies and research institutions that use the platform for preclinical and clinical decision making. ImmuniT Research operates as a data- and services-focused life sciences company supporting oncology and immunotherapy development.
ImmuniT Research
ImmuniT Research provides a platform that quantifies and monitors immunity to help predict therapeutic and diagnostic outcomes. The company combines immune analysis technologies with machine learning and AI to generate blood-based biomarkers that forecast response to immune checkpoint inhibitors such as PD-1 antibodies. Its stack includes flow cytometry and mass cytometry assays integrated into an Immunity Data Platform used for drug discovery support, biomarker development, and licensing or research collaborations. Customers are primarily pharmaceutical companies and research institutions that use the platform for preclinical and clinical decision making. ImmuniT Research operates as a data- and services-focused life sciences company supporting oncology and immunotherapy development.